Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism

Journal of Gynecologic Oncology
Shan Shan LiAlice S T Wong

Abstract

Ovarian cancer is most deadly gynecologic malignancies worldwide. Chemotherapy is the mainstay treatment for ovarian cancer. Despite the initial response is promising, frequent recurrence in patients with advanced diseases remains a therapeutic challenge. Thus, understanding the biology of chemoresistance is of great importance to overcome this challenge and will conceivably benefit the survival of ovarian cancer patients. Although mechanisms underlying the development of chemoresistance are still ambiguous, accumulating evidence has supported an integral role of cancer stem cells (CSCs) in recurrence following chemotherapy. Recently, tumor metabolism has gained interest as a reason of chemoresistance in tumors and chemotherapeutic drugs in combination with metabolism targeting approaches has been found promising in overcoming therapeutic resistance. In this review, we will summarize recent studies on CSCs and metabolism in ovarian cancer and discuss possible role of CSCs metabolism in chemoresistance.

References

Mar 10, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M De LenaA Mazzei
Oct 9, 2002·The American Journal of Pathology·Glen KristiansenSteffen Hauptmann
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Jul 2, 2003·Nature Reviews. Cancer·Roshan Agarwal, Stan B Kaye
Mar 23, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M R RaspolliniG L Taddei
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Dec 6, 2005·Nature Reviews. Cancer·Eyal Gottlieb, Ian P M Tomlinson
Apr 25, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Anne T Collins, Norman J Maitland
Sep 23, 2006·The New England Journal of Medicine·Craig T JordanMark Noble
Nov 24, 2006·Nature·Lucia Ricci-VitianiRuggero De Maria
Sep 18, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·G FerrandinaG Scambia
Feb 26, 2008·Trends in Cell Biology·Vladimir GogvadzeBoris Zhivotovsky
Jul 1, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Robert J GilliesRobert A Gatenby
May 27, 2009·Biochemical and Biophysical Research Communications·Thomas W GruntRuth Lupu
Jul 24, 2010·The American Journal of Pathology·Ernst Lengyel
Sep 14, 2010·Cancer Cell·Jian-Bin WangRichard A Cerione
Oct 5, 2010·Molecular Cancer Therapeutics·Charles N LandenAnil K Sood
Oct 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Xiaolong WeiPatricia K Donahoe
Apr 22, 2011·Nature Reviews. Cancer·Willem H KoppenolChi V Dang
Apr 27, 2011·International Journal of Cancer. Journal International Du Cancer·Xiao-Qun YeGui-Sheng Qian
Sep 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Erina VlashiFrank Pajonk
Nov 15, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jing ZhangJinsong Liu
Dec 7, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Adam D StegCharles N Landen
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Katia MeirellesXiaolong Wei
Aug 21, 2013·Clinical and Experimental Medicine·Dong Hoon SuhYong Sang Song
Sep 14, 2013·Journal of Cellular Biochemistry·Roberta PaloriniFerdinando Chiaradonna

❮ Previous
Next ❯

Citations

Aug 16, 2018·Chembiochem : a European Journal of Chemical Biology·Kristine Laws, Kogularamanan Suntharalingam
Jun 19, 2019·Angewandte Chemie·Arvin EskandariKogularamanan Suntharalingam
Mar 19, 2020·Dalton Transactions : an International Journal of Inorganic Chemistry·Arvin EskandariKogularamanan Suntharalingam
Sep 1, 2019·Journal of Experimental & Clinical Cancer Research : CR·Syed S Islam, Abdelilah Aboussekhra
Dec 13, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Marbelis Francisco FernandezBorhane Annabi
Apr 8, 2020·Frontiers in Oncology·Nastassja TerraneoJürgen Grünberg
Sep 4, 2019·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·Cid Almeida de LimaRosekeila Simões Nomelini
Mar 27, 2020·Frontiers in Oncology·Maria Andrea DesbatsMonica Montopoli
Sep 12, 2019·Frontiers in Oncology·Olorunseun O Ogunwobi, Adithya Kumar
Oct 23, 2019·BMC Complementary and Alternative Medicine·Jinsha KorothBibha Choudhary
Nov 24, 2020·Frontiers in Cell and Developmental Biology·Liwen ZhangMiao He
May 16, 2019·Molecular Cancer Research : MCR·Basmina ParmakhtiarJohn P Fruehauf
Oct 19, 2020·International Journal of Pharmaceutics·Yuan LiHuile Gao
Feb 19, 2021·Biochimica Et Biophysica Acta. Reviews on Cancer·Chit TamChi Chiu Wang
Jun 22, 2021·Journal of Obstetrics and Gynaecology of India·Mala SrivastavaAnkita Srivastava
Sep 3, 2021·Journal of Experimental & Clinical Cancer Research : CR·Nazanin KarimniaAndrew N Stephens
Oct 31, 2021·Journal of Hematology & Oncology·Shuiqing LiuManran Liu

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.